Cancer Types: Hepatocellular carcinoma (HCC), breast cancer, colon cancer, and prostate cancer.
Food Occurrences: Found in Barberries, as well as the roots and bark of plants like Goldenseal and Oregon Grape. In Chinese medicine, it is isolated from Coptidis Rhizoma (Huanglian).
Berberine is an isoquinoline alkaloid with a wide range of pharmacological benefits, including anti-inflammatory and anti-diabetic properties. In cancer treatment, it acts as a strong anti-proliferative compound that can make cancer cells more responsive to both radiotherapy and chemotherapy.
It works by influencing several signaling pathways, such as inhibiting the mTOR pathway and reducing P-glycoprotein (P-gp) activity to counter multidrug resistance. Researchers are now aiming to boost its low bioavailability with nanoparticle-based delivery systems, which have shown promise in improving its effectiveness against breast and liver cancers. Its role in regulating gut microbiota also opens up a fresh approach to managing cancer on a systemic level.
Remainder of Report & Sources:
Mechanisms: Regulation of autophagy, pro-apoptotic effects, and suppression of metastatic migration.
Combinations: Synergizes with rapamycin to inhibit tumor growth.
Molecular Targets: Acts as a potent AMPK activator (similar to metformin), which suppresses energy-hungry cancer cell growth. It is a known inhibitor of P-glycoprotein (P-gp), a pump that cancer cells use to eject chemotherapy drugs.
Bioavailability: Extremely low (less than 1%) due to poor absorption and rapid “first-pass” metabolism in the liver.
Cross-Links:
Curcumin: Synergistically inhibits growth in Breast Cancer (MCF-7 and MDA-MB-231 lines) by inducing autophagic cell death via the JNK/Bcl-2/Beclin1 pathway.
Resveratrol: Combined use enhances the regulation of lipid metabolism and SIRT1 activation.
